Ullrich Munzel

3.8k total citations
57 papers, 2.6k citations indexed

About

Ullrich Munzel is a scholar working on Physiology, Immunology and Allergy and Statistics and Probability. According to data from OpenAlex, Ullrich Munzel has authored 57 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 19 papers in Immunology and Allergy and 13 papers in Statistics and Probability. Recurrent topics in Ullrich Munzel's work include Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (19 papers) and Statistical Methods in Clinical Trials (9 papers). Ullrich Munzel is often cited by papers focused on Asthma and respiratory diseases (22 papers), Allergic Rhinitis and Sensitization (19 papers) and Statistical Methods in Clinical Trials (9 papers). Ullrich Munzel collaborates with scholars based in Germany, United States and Belgium. Ullrich Munzel's co-authors include Edgar Brunner, Joachim Maus, Phillip A. Low, P. James B. Dyck, Р. Р. Самигуллин, Dan Ziegler, Ludwig A. Hothorn, Jean Bousquet, David Price and Claus Bachert and has published in prestigious journals such as Diabetes Care, Journal of Allergy and Clinical Immunology and Journal of Bone and Mineral Research.

In The Last Decade

Ullrich Munzel

56 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ullrich Munzel Germany	26	918	523	374	326	314	57	2.6k
Ian N.M. Day United Kingdom	44	764 0.8×	54 0.1×	259 0.7×	88 0.3×	369 1.2×	162	7.5k
Juan R. González Spain	36	468 0.5×	45 0.1×	75 0.2×	211 0.6×	397 1.3×	149	4.6k
Josée Dupuis United States	44	781 0.9×	46 0.1×	144 0.4×	111 0.3×	631 2.0×	199	6.9k
Min Chen China	37	295 0.3×	49 0.1×	250 0.7×	149 0.5×	413 1.3×	227	5.0k
Christoph Lange United States	43	1.7k 1.8×	174 0.3×	70 0.2×	162 0.5×	940 3.0×	162	5.3k
Cristen J. Willer United States	31	687 0.7×	47 0.1×	236 0.6×	88 0.3×	399 1.3×	82	9.0k
Damjan Vukcevic Australia	13	609 0.7×	50 0.1×	160 0.4×	93 0.3×	277 0.9×	21	6.7k
Richard A. Stone United States	52	919 1.0×	39 0.1×	185 0.5×	109 0.3×	343 1.1×	226	9.1k
Mario Falchi United Kingdom	32	782 0.9×	28 0.1×	390 1.0×	27 0.1×	175 0.6×	88	4.6k
Ole Christian Lingjærde Norway	39	203 0.2×	46 0.1×	196 0.5×	132 0.4×	581 1.9×	174	7.0k

Countries citing papers authored by Ullrich Munzel

Since Specialization

Citations

This map shows the geographic impact of Ullrich Munzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Munzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Munzel more than expected).

Fields of papers citing papers by Ullrich Munzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ullrich Munzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Munzel. The network helps show where Ullrich Munzel may publish in the future.

Co-authorship network of co-authors of Ullrich Munzel

This figure shows the co-authorship network connecting the top 25 collaborators of Ullrich Munzel. A scholar is included among the top collaborators of Ullrich Munzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ullrich Munzel. Ullrich Munzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bousquet, Jean, Eli O. Meltzer, Peter Couroux, et al.. (2018). Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1726–1732.e6. 40 indexed citations

Brixner, Diana, et al.. (2016). IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care. 32(6). 371–375. 5 indexed citations

Bachert, Claus, Giorgio Walter Canonica, Joaquim Mullol, et al.. (2015). MP29-02*'s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis. Allergy. 70. 504–505. 3 indexed citations

Harrow, B., et al.. (2015). Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitis. Value in Health. 18(3). A172–A173. 1 indexed citations

Berger, William E., Shailen Shah, Phil Lieberman, et al.. (2014). Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis. The Journal of Allergy and Clinical Immunology In Practice. 2(2). 179–185. 47 indexed citations

Canonica, Giorgio Walter, Jean Bousquet, Joaquim Mullol, et al.. (2013). A new allergic rhinitis therapy (MP29-02) is more effective than current first line monotherapies in providing allergic rhinitis patients relief from their nasal and ocular symptoms (rTNSS, rT5SS, rT7SS). Ghent University Academic Bibliography (Ghent University). 3 indexed citations

Bousquet, Jean, Warner Carr, Jonine L. Bernstein, et al.. (2012). MP29-02 is effective for the symptomatic treatment of seasonal allergic rhinitis even in those with very severe disease: a meta-analysis. Allergy. 67. 336–336. 1 indexed citations

Derendorf, Hartmut, Ullrich Munzel, Joachim Maus, et al.. (2012). Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray. British Journal of Clinical Pharmacology. 74(1). 125–133. 28 indexed citations

Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2009). Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe.. PubMed. 18(6). 677–82. 81 indexed citations

10.

Munzel, Ullrich. (2009). Nonparametric non‐inferiority analyses in the three‐arm design with active control and placebo. Statistics in Medicine. 28(29). 3643–3656. 12 indexed citations

11.

Nguyen, Duc Tung, et al.. (2008). Single-Dose Pharmacokinetics and Safety Pharmacodynamics of Formoterol Delivered by Two Different Dry Powder Inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(3). 309–320. 4 indexed citations

12.

Hermann, Róbert, Jürgen Borlak, Ullrich Munzel, et al.. (2006). The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. The Pharmacogenomics Journal. 6(3). 211–219. 15 indexed citations

13.

Horak, Friedrich, et al.. (2005). Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Current Medical Research and Opinion. 22(1). 151–157. 58 indexed citations

14.

Munzel, Ullrich, et al.. (2005). Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers. Current Medical Research and Opinion. 21(6). 827–833. 12 indexed citations

15.

Obenauer, Silvia, Susanne Luftner-Nagel, D. von Heyden, et al.. (2002). Screen film vs full-field digital mammography: image quality, detectability and characterization of lesions. European Radiology. 12(7). 1697–1702. 73 indexed citations

16.

Mursch, Kay, et al.. (2001). Blood Flow Velocities in the Basal Vein after Subarachnoid Haemorrhage A Prospective Study Using Transcranial Duplex Sonography. Acta Neurochirurgica. 143(8). 793–800. 21 indexed citations

17.

Meller, J., G. Altenvoerde, Ullrich Munzel, et al.. (2000). Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. European Journal of Nuclear Medicine and Molecular Imaging. 27(11). 1617–1625. 132 indexed citations

18.

Legler, Tobias J., J. Riggert, G. Simson, et al.. (2000). Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion‐transmitted HCV infection. Transfusion. 40(10). 1192–1197. 24 indexed citations

19.

Humpe, Andreas, J. Riggert, Ullrich Munzel, et al.. (1999). A prospective, randomized, sequential, crossover trial of large‐volume versus normal‐volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion. 39(10). 1120–1127. 31 indexed citations

20.

Rüther, E., et al.. (1999). Antidepressant Action of Sulpiride. Results of a Placebo-Controlled Double-Blind Trial. Pharmacopsychiatry. 32(4). 127–135. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact